ArticlePLoS computational biology2025
Calibration of transmission-dynamic infectious disease models: A scoping review and reporting framework.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A model for the epidemiological impact of tuberculosis policy options.Bulletin of the World Health Organization · 2026Article
- Economic evaluation of school scoliosis screening in Gannan Tibetan autonomous prefecture, Gansu Province: a cost-utility analysis based on decision tree-Markov model.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
OBJECTIVE/
backgroundTransmission-dynamic models are commonly used to study infectious disease epidemiology. Calibration involves identifying model parameter values that align model outputs with observed data or other evidence. Inaccurate calibration and inconsistent reporting produce inference errors and limit reproducibility, compromising confidence in the validity of modeled results. No standardized framework exists for reporting on calibration of infectious disease models, and an understanding of current calibration approaches is lacking.
methodsWe developed the Purpose-Inputs-Process-Outputs (PIPO) framework for reporting calibration practices and applied it in a scoping review to assess calibration approaches and evaluate reporting comprehensiveness in transmission-dynamic models of tuberculosis, HIV and malaria published between January 1, 2018, and January 16, 2024. We searched relevant databases and websites to identify eligible publications, including peer-reviewed studies where these models were calibrated to empirical data or published estimates.
resultsWe identified 411 eligible studies encompassing 419 models, with 74% (n = 309) being compartmental models and 20% (n = 81) individual-based models (IBMs). The predominant analytical purpose was to evaluate interventions (71% of models, n = 298). Parameters were calibrated mainly because they were unknown or ambiguous (40%, n = 168), or because determining their value was relevant to the scientific question beyond being necessary to run the model (20%, n = 85). The choice of calibration method was significantly associated with model structure (p-value<0.001) and stochasticity (p-value = 0.006), with approximate Bayesian computation more frequently used with IBMs and Markov-Chain Monte Carlo with compartmental models. Regarding reporting comprehensiveness, all PIPO framework items were reported in 4% (n = 18) of models; 11-14 items in 66% (n = 277), and 10 or fewer items in 28% (n = 124). Implementation code was the least reported, available in only 20% (n = 82) of models.
conclusionsReporting on calibration is heterogeneous in recent infectious disease modeling literature. Our proposed framework for reporting of calibration approaches could support improved reproducibility and credibility of modeled analyses.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.